Analysis of complications after blood components’ transfusions
Languages of publication
Complications after blood components still constitute an important clinical problem and serve as limitation of liberal-transfusion strategy. The aim of the study was to present the 5-year incidence of early blood transfusions complications and to assess their relation to the type of the transfused blood components. Material and methods. 58,505 transfusions of blood components performed in the years 2006-2010 were retrospectively analyzed. Data concerning the amount of the transfused blood components and the numbers of adverse transfusion reactions reported to the Regional Blood Donation and Treatment Center (RBDTC) was collected. Results. 95 adverse transfusion reactions were reportedto RBDTC 0.16% of alldonations (95/58 505) - 58 after PRBC transfusions, 28 after platelet concentrate transfusions and 9 after FFP transfusion. Febrile nonhemolytic and allergic reactions constitute respectively 36.8% and 30.5% of all complications. Conclusion. Nonhemolyticand allergic reactions are the most common complications of blood components transfusion and they are more common after platelet concentrate transfusions in comparison to PRBC and FFP donations.
1 - 4 - 2015
2 - 4 - 2015
3 - 7 - 2015
- Department of Emergency Medicine and Disaster Medicine Medical University in Łódź
- Department of Diagnostics, Copernicus Memorial Hospital in Łódź
- Department of Plastic, Reconstructive and Aesthetic Surgery, Medical University in Łódź
- Department of Cranio-Maxillofacial and Oncological Surgery, Medical University in Łódź, email@example.com
- 1. Goodnough LT , Shander A: Risks and Complications of Blood Transfusions: Optimizing Outcomes for Patients with Chemotherapy-Induced Anemia. Adv Stud Med 2008; 8: 357-62.
- 2. Shander A: Emerging risks and outcomes of blood transfusion in surgery. Semin Hematol 2004; 41: 117-24.
- 3. Webert KE, Cserti CM, Hannon J et al.: Proceedings of a Consensus Conference: pathogen inactivation- making decisions about new technologies. Transfus Med Rev 2008; 22: 1-34.
- 4. Vasconcelos E, Seghatchian J: Bacterial contamination in blood components and preventative strategies: an overview. Transfus Apher Sci 2004; 31: 155.
- 5. Goodnough LT , Shander A, Brecher ME: Transfusion medicine: looking to the future. Lancet 2003; 361: 161.
- 6. Jacobs MR, Palavecino E, Yomtovian R: Don't bug me: the problem of bacterial contamination of blood components--challenges and solutions. Transfusion 2001; 41: 1331.
- 7. Brojer E: Czynniki zakaźne przenoszone przez krew. OINPHARMA, Warszawa 2008.
- 8. Hillyer CD , Josephson CD , Blajchman MA et al.: Bacterial contamination of blood components: risks, strategies, and regulation: joint ASH and AABB educational session in transfusion medicine. Hematology Am Soc Hematol Educ Program 2003; 575-89.
- 9. Dodd RY : Current risk fortransfusion transmitted infections. Curr Opin Hematol 2007; 14: 671-76.
- 10. Shander A: Anemia in the critically ill. Crit Care Clin 2004; 20: 159-78.
- 11. Knowles S, Cohen H, on behalf of the Serious Hazards of Transfusion (SHOT) Steering Group. The 2010 Annual SHOT Report, 2011.
- 12. Glance LG, Dick AW , Mukamel DB et al.: Association between intraoperative blood transfusion and mortality and morbidity in patients undergoing noncardiac surgery. Anesthesiology 2011; 114: 283-92.
- 13. Juffermans NP, Prins DJ, Vlaar AP et al.: Transfusion-related risk of secondary bacterial infections in sepsis patients: a retrospective cohort study. Shock 2011; 35: 355-59.
- 14. Salvin JW, Scheurer MA, Laussen PC et al.: Blood transfusion after pediatric cardiac surgery is associated with prolonged hospital stay. Ann Thorac Surg 2011; 91: 204-10.
- 15. Nuis RJ, Van Mieghem NM, Tzikas A et al.: Frequency, determinants, and prognostic effects of acute kidney injury and red blood cell transfusion in patients undergoing transcatheter aortic valve implantation. Catheter Cardiovasc Interv 2011; 77: 881-89.
- 16. Chau JK, Harris JR, Seikaly HR : Transfusion as a predictor of recurrence and survival in head and neck cancer surgery patients. J Otolaryngol Head Neck Surg 2010; 39: 516-22.
- 17. Möhnle P, Snyder-Ramos SA , Miao Y et al.: Postoperative red blood cell transfusion and morbid outcome in uncomplicated cardiac surgery patients. Intensive Care Med 2011; 37: 97-109.
- 18. Wu WC , Smith TS , Henderson WG et al.: Operative blood loss, blood transfusion, and 30-day mortality in older patients after major noncardiac surgery. Ann Surg 2010; 252: 11-17.
- 19. Hearnshaw SA , Logan RF , Palmer KR et al.: Outcomes following early red blood cell transfusion in acute upper gastrointestinal bleeding. Aliment Pharmacol Ther 2010; 32: 215-24.
- 20. Veenith T, Sharples L, Gerrard C et al.: Survival and length of stay following blood transfusion in octogenarians following cardiac surgery. Anaesthesia 2010; 65: 331-36.
- 21. Pedersen AB, Mehnert F, Overgaard S et al.: Allogeneic blood transfusion and prognosis following total hip replacement: a population-based follow up study. BMC Musculoskelet Disord 2009; 10: 167.
- 22. vanStraten AH , Bekker MW, Soliman Hamad MA et al.: Transfusion of red blood cells: the impact on short-term and long-term survival after coronary artery bypass grafting, a ten-year follow-up. Interact Cardiovasc Thorac Surg 2010; 10: 37-42.
- 23. Whitson BA, Huddleston SJ, Savik K et al.: Risk of adverse outcomes associated with blood transfusion after cardiac surgery depends on the amount of transfusion. J Surg Res 2010; 158: 20-27.
- 24. Barrett NA , Kam PC: Transfusion-related acute lung injury: a literature review. Anaesthesia 2006; 61: 777-85
- 25. Shander A, Popovsky MA: Understanding the consequences of transfusion-relatedacute lung injury. Chest 2005; 128: 598S-604S
- 26. Shander A, Javidroozi M, Ozawa S et al.: What is really dangerous: anaemia or transfusion? Br J Anaesth 2011; 107: 41-59.
- 27. Goodnough LT : Risks of blood transfusion. Anesthesiol Clin North America 2005; 23: 241-52.
Publication order reference